跳至主要内容
临床试验/NCT00449462
NCT00449462已完成不适用

The Effect of Conjugated Linoleic Acid Intake on Liver and Kidney Function in Healthy Volunteers (CLAxon-Study)

Wageningen University2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2007年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
creatinine clearance

研究概览

简要总结

The knowledge of the health effects of CLA on the human body is limited. However, CLA supplements are sold over the counter in several countries and various techniques are used to increase the content of CLA in food.

The CLAxon-study will be performed to investigate wether high doses of CLA can be safely given to healthy human volunteers.

详细描述

Each volunteer receives CLA enriched products for a total of 3 weeks containing approximately 20g CLA per day. A control group is not needed. If three subjects or more show one or more blood values for liver and kidney function above predefined limits the study will be terminated.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-60 years
  • serum total cholesterol < 8.0 mmol/L
  • serum triglycerides < 3.0 mmol/L
  • ALAT < 45 IU/L
  • ASAT < 41 IU/L
  • amylase 35-130 U/L
  • alkaline phosphatase 40-125 U/L
  • bilirubin < 17 µmol/L
  • gamma-glutamyltranspeptidase > 75 U/L (men) and < 40 U/L (women)
  • lactate dehydrogenase 230-485 U/L
  • creatinine clearance >= 90 mL/min
  • fasting glucose levels 70-115 mg/dL
  • fasting insulin levels 5-30 mU/L

排除标准

  • use of cholesterol lowering medication
  • high alcohol intake
  • BMI > 30
  • chronic diseases (such as diabetes, cardiovascular disease, kidney and liver dysfunction)
  • pregnancy

结局指标

主要结局

creatinine clearance

amylase

bilirubin

alkaline phosphatase

gamma-glutamyltranspeptidase

lactate dehydrogenase

ASAT

ALAT

次要结局

  • total cholesterol
  • HDL cholesterol
  • LDL cholesterol
  • triglycerides
  • fatty acids

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验